Casdin Capital’s Century Therapeutics IPSC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $686K | Sell |
1,228,190
-1,984,126
| -62% | -$1.11M | 0.06% | 29 |
|
|
2025
Q1 | $1.53M | Sell |
3,212,316
-1,978,190
| -38% | -$942K | 0.12% | 35 |
|
|
2024
Q4 | $5.24M | Buy |
5,190,506
+1,978,190
| +62% | +$2M | 0.35% | 28 |
|
|
2024
Q3 | $5.49M | Sell |
3,212,316
-1,978,190
| -38% | -$3.38M | 0.37% | 27 |
|
|
2024
Q2 | $13.2M | Buy |
5,190,506
+1,984,126
| +62% | +$5.06M | 1.01% | 21 |
|
|
2024
Q1 | $13.4M | Hold |
3,206,380
| – | – | 1% | 22 |
|
|
2023
Q4 | $10.6M | Hold |
3,206,380
| – | – | 1.04% | 20 |
|
|
2023
Q3 | $6.41M | Hold |
3,206,380
| – | – | 0.71% | 25 |
|
|
2023
Q2 | $10.1M | Hold |
3,206,380
| – | – | 0.89% | 24 |
|
|
2023
Q1 | $11.1M | Hold |
3,206,380
| – | – | 0.92% | 27 |
|
|
2022
Q4 | $16.4M | Hold |
3,206,380
| – | – | 1.27% | 23 |
|
|
2022
Q3 | $31.7M | Hold |
3,206,380
| – | – | 2.08% | 13 |
|
|
2022
Q2 | $26.9M | Hold |
3,206,380
| – | – | 2.28% | 13 |
|
|
2022
Q1 | $40.4M | Hold |
3,206,380
| – | – | 1.81% | 24 |
|
|
2021
Q4 | $50.9M | Hold |
3,206,380
| – | – | 1.43% | 25 |
|
|
2021
Q3 | $80.7M | Hold |
3,206,380
| – | – | 2.01% | 19 |
|
|
2021
Q2 | $94.1M | Buy |
+3,206,380
| New | +$94.1M | 2.39% | 16 |
|